Advanced search
Publication Cover
Future Cardiology Volume 7, 2011 - Issue 2
Submit an article Journal homepage
163
Views
0
CrossRef citations to date
0
Altmetric
Review

ABO Blood Groups and Thrombosis: A Causal association, But is There Value in screening?

Peter Clark1 Department of Transfusion Medicine East of Scotland Blood Transfusion Centre Ninewells Hospital and Medical SchoolDundeeDD1 9SYUK.Correspondence[email protected]
&
Olivia Wu2 Department of Public Health and Health Policy University of GlasgowGlasgowUK
Pages 191-201 | Published online: 31 Mar 2011

Bibliography

  • Egeberg O : Inherited antithrombin deficiency causing thrombophilia.Thromb. Diath. Haemorrh., 13, 516–530 (1965).
  • Kyrle P et al. , Erich Minar E, Hirschl M : High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N. Engl. J. Med., 343, 457–462 (2000).
  • Christiansen S , CannegieterS, KosterT, VandenbrouckeJ, RosendaalF: Thrombophilia, clinical factors, and recurrent venous thrombotic events.JAMA, 293, 2352–2361 (2005).
  • Wu O , BayoumiN, VickerM, ClarkP: ABO(H) blood groups and vascular disease: a systematic review and meta-analysis.J. Thromb. Haemost., 6, 62–69 (2008).
  • Tirado I , MateoJ, SoriaJet al.: The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism.Thromb. Haemost., 93, 468–474 (2005).
  • Daniels G : Human Blood Groups (2nd Edition). Blackwell Science Ltd, Oxford, UK (2002).
  • O‘Donnell J , Mille-BakerB, LaffanM: Human umbilical vein endothelial cells differ from other endothelial cells in failing to express ABO blood group antigens.J. Vasc. Res., 37, 540–547 (2000).
  • Oriol B , MolliconeR, CoullinP, DalixA, CandelierJ: Genetic regulation of the expression of ABH and Lewis antigens in tissues.APMIS Suppl., 27, 29–38 (1992).
  • Sodetz J , PaulsonJ, McKeeP: Carbohydrate composition and identification of blood group A, B, and H oligosaccharide structures on human factor VIII/von Willebrand factor.J. Biol. Chem., 254, 10754–10760 (1979).
  • Matsui T , FujimuraY, NishidaS, TitaniK: Human plasma α 2-macroglobulin and von Willebrand factor possess covalently linked ABO(H) blood group antigens in subjects with corresponding ABO phenotype.Blood, 82, 863–868 (1993).
  • Wagner D , MarderV: Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization.J. Cell. Biol., 99, 2123–2130 (1984).
  • Canis K , McKinnonT, NowakAet al.: The plasma von Willebrand factor O-glycome comprises a surprising variety of structures including ABH antigens and disialosyl motifs.J. Thromb. Haemost., 8, 137–145 (2010).
  • Sarode J , GoldsteinJ, SussmanI, NagelR, TsaiH: A and B blood group antigens are present on plasma (but not on platelet) von Willebrand factor and their removal decreases ristocetin co-factor activity.Blood, 90, 435A (1997).
  • Brown S , BowenD, ElisD, CollinsP: von Willebrand factor ABO blood group associated antigens: immunological detection and distribution.Blood, 90, 466A (1997).
  • Brown S , CollinsP, BowenD: Heterogeneous detection of A-antigen on von Willebrand factor derived from platelets, endothelial cells and plasma.Thromb. Haemost., 87, 990–996 (2002).
  • McCallum C , PeakeI, NewcombeRet al.: Factor VIII levels and blood group antigens.Thromb. Haemost., 50, 757 (1983).
  • Orstavik K , MagnusP, ResinerH, BergK, GrahamJ, NanceW: Factor VIII and factor IX in a twin population: evidence for a major effect of ABO locus on factor VIII level.Am. J. Hum. Genet., 37, 89–101 (1985).
  • Gill J , Endres-BrooksJ, BauerP, MarksW, MontgomeryR: The effect of ABO blood group on the diagnosis of von Willebrand disease.Blood, 69, 1691–1695 (1987).
  • Shima M , FufimuraY, NishiyamaTet al.: ABO blood group genotype and plasma von Willebrand factor in normal individuals.Vox Sang., 68, 236–240 (1995).
  • Souto J , AlmasyL, Muñiz-DiazEet al.: Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time.Arterioscler. Thromb. Vasc. Biol., 20, 2024–2028 (2000).
  • O‘Donnell J , BoultonF, ManningR, LaffanM: Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels.Arterioscler. Thromb. Vasc. Biol., 22, 335–341 (2002).
  • Sousa N , Anicchino-BizzacchiJ, LocatelliM, CastroV, Barjas-CastroM: The relationship between ABO groups and subgroups, factor VIII and von Willebrand factor.Haematologica, 92, 236–239 (2007).
  • Schleef M , ErwinS, DickA, FrankJ, SchrammW, SpannaglM: Relationship between ABO and secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.Br. J. Haematol., 128, 100–107 (2005).
  • Morelli V , de Visser M, Vos H, Bertina R, Rosendaal F: ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden. J. Thromb. Haemost., 3, 183–185 (2005).
  • Trégouët D et al. -A, Heath S, Saut N : Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood, 113, 5298–5303 (2009).
  • Paiva S , SabinoA, CarvalhoMet al.: Polymorphisms in exons 6 and 7 of the ABO locus and their association with venous thrombosis in young Brazilian patients.Blood Coag. Fibrinol., 20, 122–128 (2009).
  • Morelli V , de Visser M, van Tilburg N: ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens. Thromb. Haemost., 97, 534–541 (2007).
  • Brown S , EldridgeA, CollinsP, BowenD: Increased clearance of von Willebrand factor antigen post-DDAVP in Type 1 von Willebrand disease: is it a potential pathogenic process?J. Thromb. Haemost., 1, 1714–1717 (2003).
  • Sweeney J , HoernigL: Intraplatelet von Willebrand factor and AO blood group.Thromb. Res., 69, 393–398 (1992).
  • Gallinaro L , CattiniM, SztukowskaMet al.: A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence von Willebrand factor.Blood, 111, 3540–3545 (2008).
  • Bowen D : An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13.J. Thromb. Haemost., 1, 33–40 (2003).
  • O‘Donnell J , McKinnnonT, CrawleyJ, LaneD, LaffanM: Bombay phenotype is associated with reduced plasma vWF levels and an increased susceptibility to ADAMTS13 proteolysis.Blood, 106, 1988–1991 (2005).
  • Badirou I , KurdiM, RayesJet al.: von Willebrand factor clearance does not involve proteolysis by ADAMTS-13.J. Thromb. Haemost., 8, 2338–2340 (2010).
  • van Schooten C , ShahbaziS, GrootEet al.: Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivo.Blood, 112, 1704–1712 (2010).
  • Ohira T , CushmanM, TsaiMet al.: ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).J. Thromb. Haemost., 5, 1455–1461 (2007).
  • Clark P , WalkerID, GreerI: Acquired activated protein-C resistance in pregnancy and association with increased thrombin generation and fetal weight.Lancet, 353, 292–293 (1999).
  • Clark P , WalkerID: The phenomenon known as acquired activated protein C resistance.Br. J. Haematol., 115, 767–773 (2001).
  • Clark P , SattarN, WalkerI, GreerI: The Glasgow Outcome, APCR and Lipid (GOAL) Pregnancy Study: significance of pregnancy associated activated protein C resistance.Thromb. Haemost., 85, 30–35 (2001).
  • Favaloro E , SoltaniS, McDonaldJ, GrezchnikE, EastonL: Activated protein C resistance: the influence of ABO-blood group, gender and age.Thromb. Res., 117, 665–670 (2006).
  • Clark P , RosingJ, CurversJet al.: The Glasgow APC resistance and lipid (GOAL) pregnancy study: pregnancy associated APC resistance.Thromb. Haemost., 86(Suppl.), 3002 (2001).
  • Colonia V , RoisenbergI: Investigation of associations between ABO blood groups and coagulation, fibrinolysis, total lipids, cholesterol and triglycerides.Hum. Genet., 48, 221–230 (1979).
  • Fagerhol MK , AbildgaardU, KornstadL: Antithrombin III concentration and ABO blood group.Lancet, 1971, 664–665 (1971).
  • Rodeghiero F , TosettoA: The VITA Project: population-based distributions of protein C, antithrombin III, heparin-cofactor II and plasminogen – relationship with physiological variables and establishment of reference ranges.Thromb. Haemost., 76, 226–233 (1996).
  • Stormorken H , ErikssenJ: Plasma antithrombin III and factor VIII antigen in relation to angiographic findings, angina and blood groups in middle-aged men.Thromb. Haemost., 38, 874–880 (1977).
  • Jenkins P , O‘DonnellJ: ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?Transfusion, 46, 1836–1844 (2006).
  • Langman M , ElwoodP, GooteJ, RyrieD: ABO and Lewis blood groups and serum cholesterol.Lancet, 2, 607–609 (1969).
  • Oliver M , CummingR, GeigerovaH: Serum cholesterol and ABO and Rhesus blood groups.Lancet, 2(7621), 605–606 (1969).
  • Garrison R , HavlikR, HarrisR, FeinleibM, KannelW, PadgettS: ABO blood group and cardiovascular disease. The Framingham study.Atherosclerosis, 25, 311–318 (1976).
  • Banerjee B , SahaN: Interrelation of serum cholesterols, ABO-Rh blood groups and body fat.Med. J. Malaysia, 24, 41–44 (1969).
  • Cronenwett J , DavisJ, GarrettE: ABO blood group and serum lipids in female atherosclerosis.J. Cardiovasc. Surg., 124, 658–661 (1983).
  • Horby J , GyrtrupH, GrandeP, VestergaardA: Relation of serum lipoproteins and lipids to the ABO blood groups in patients with intermittent claudication.J. Cardiovasc. Surg., 30, 533–537 (1989).
  • Green D , JarrettO, RuthK, FolsomA, LiuK. Relationship among Lewis phenotype, clotting factors and other cardiovascular risk factors in young adults. J. Lab. Clin. Med., 125, 334–339 (1995).
  • Blann A , DalyRD, AmiralJ: The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules.Br. J. Haematol., 92, 498–500 (1996).
  • Melzer D , PerryJ, HernandezDet al.: A genome-wide association study identifies protein quantitative trait loci (pQTLs).PLoS Genet., 4, E1000072 (2008).
  • Paré G , ChasmanD, KelloggMet al.: Novel asociation of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women.PLoS Genet., 4, E1000118 (2008).
  • Clark P , JordanF, PearsonCet al.: Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated by thrombin in human monocytes and THP-1 cells in vitro and in pregnant subjects in vivo.Thromb. Haemost., 89, 1043–1051 (2003).
  • Heit J : The epidemiology of venous thromboembolism in the community.Arterioscler. Thromb. Vasc. Biol., 28, 370–372 (2008).
  • Poort SR , RosendaalFR, ReitsmaPH, BertinaRM: A common genetic variation in the 3´-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.Blood, 88, 3698–3703 (1996).
  • Bertina RM , KoelemanBPC, KosterTet al.: Mutation in blood-coagulation factor-V associated with resistance to activated protein-C.Nature, 369, 64–67 (1994).
  • Lijfering W , RosendaalF, CannegieterS: Risk factors for venous thrombosis – current understanding from an epidemiological point of view.Br. J. Haematol., 149, 824–833 (2010).
  • Robert A , AillaudMF, EschwegeV, RandrianjohanyA, ScarabinY, Juhan-VagueI: ABO blood group and risk of venous thrombosis in heterozygous carriers of factor V Leiden.Thromb. Haemost., 83, 630–631 (2000).
  • Procare-GEHT group: ABO blood group but not haemostatic genetic polymorphisms significantly influence the thrombotic risk: a study of 180 homozygotes for the factor V Leiden mutation. Br. J. Haematol., 135, 697–702 (2006).
  • Jukic I , Bingulac-PopovicJ, DogicVet al.: ABO blood groups and genetic risk factors for thrombosis in Croatian population.Croatian Med. J., 50, 550–558 (2009).
  • Lima M et al. , de Oliveira-FilhoI A, Campos J : Increased risk of venous thrombosis by AB alleles of the ABO blood group and Factor V Leiden in a Brazilian population. Genet. Mol. Biol., 32, 264–267 (2009).
  • Miñano A , OrdóñezA, EspañaFet al.: ABO blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.Haematologica, 93, 729–734 (2008).
  • Gonzalez OAJ , MedinaRJM, MartinL, AlvarezV, CotoE: The O blood group protects against venous thromboembolism in individuals with the factor V Leiden but not the prothrombin (factor II G20210A) mutation.Blood Coagul. Fibrinol., 10, 303–307 (1999).
  • Canonico M , OlieV, CarcaillonL, Tubert-BitterP, ScarabinP: Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: the ESTHER study.Thromb. Haemost., 99, 246–248 (2008).
  • Smith E , LoweF, LeeA, RumleyA, LengG, FowkesF: Smoking, hemoheologic factors and progression of peripheral arterial disease in patients with claudication.J. Vasc. Surg., 28, 129–135 (1998).
  • Blann A , McCollumC: Hemostatic risk factors in patients with vascular disease.Atherosclerosis, 93, 255–256 (1992).
  • Woodburn K , RumleyA, LoweGDO, PollockJG: Thrombotic mediators and patient selection in infra-inguinal revascularisation surgery.Int. Angiol., 13(Suppl. 1), 51 (1994).
  • Clark P , WuO: ABO(H) blood groups and pre-eclampsia.Thromb. Haemost., 100, 469–474 (2008).
  • Amin N , TahirS, AbadiN: Association of blood groups with preeclamptic toxaemia.Med. Sci. Res., 17, 861–862 (1989).
  • May D : Maternal blood group A and pre-eclampsia.Br. Med. J., 4, 22 (1973).
  • Spinillo A , CapuzzoE, BaltaroF, PiazziG, IasciA: Case–control study of maternal blood group and severe pre-eclampsia.J. Hum. Hypertens., 9, 623–625 (1995).
  • Hiltunen L , LaivouriH, RautanenAet al.: Blood group AB and factor V Leiden as risk factors for pre-eclampsia: a population based nested case–control study.Thromb. Res., 124, 167–173 (2009).
  • Clark P , MeiklejohnD, O‘SullivanA, VickersM, GreavesM: The relationship of ABO, Lewis and Secretor blood groups with cerebral ischaemia of arterial origin.J. Thromb. Haemost., 3, 2105–2108 (2005).
  • Wiggins K , SmithN, GlazerNet al.: ABO genotype and risk of thrombotic events and hemorrhagic stroke.J. Thromb. Haemost., 7, 263–269 (2009).
  • Ionescu DA , MarcuI, BicescuE: Cerebral thrombosis, cerebral haemorrhage, and ABO blood-groups.Lancet, 1, 278–280 (1976).
  • Bayoumi NA , MacLeodMJ, GreavesM, VickersMA: ABO blood groups in cerebrovascular accident.Br. J. Haematol., 133(Suppl. 1), 51 (2006).
  • Bronte-Stewart B , BothaM, KrutL: ABO blood groups in relation to ischaemic heart disease.Br. Med. J., I, 1646–1650 (1962).
  • Oliver M , CummingR: Blood groups and heart disease.Br. Med. J., II, 51 (1962).
  • Allan TM , DawsonAA: ABO blood groups and ischaemic heart disease in men.Br. Heart J., 968, 377–382 (1968).
  • Maurer R , HickeyN, MulcahyR: ABO and Rh blood groups in patients with coronary heart disease.Irish J. Med. Sci., 2, 105–108 (1969).
  • Erikssen J , ThaulowE, StormorkenH, BrendemoenO, HellemA: ABO blood groups and coronary artery disease (CHD): a study in subjects with severe and latent CHD.Thromb. Haemost., 43, 137–140 (1980).
  • Medalie J , LeveneC, PapierCet al.: Blood groups, myocardial infarction and angina pectoris among 10.000 adult males.N. Engl. J. Med., 285, 1348–1353 (1971).
  • Suadicani P , HeinHO, GyntelbergF: Socioeconomic status, ABO phenotypes and risk ischaemic heart disease: an 8 year follow-up in the Copenhagen Male study.J. Cardiovasc. Risk, 7, 277–283 (2000).
  • Anvari M , BoroumandA, EmamiBet al.: ABO blood group and coronary artery disease in Iranian patients awaiting coronary bypass graft surgery: a review of 10.641 cases.Lab. Med., 40, 528–530 (2009).
  • Meade T , CooperJ, StirlingY. Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br. J. Haematol., 88, 601–607 (1994).
  • Whincup P , CookD, PhillipsA, ShaperA: ABO blood groups and ischaemic heart disease in British men.Br. Med. J., 300, 1679–1682 (1990).
  • Roest M , VoorbijH, BaredrechtA, PeetersP, van der Schouw Y: Risk of acute ischemic heart disease in postmenopausal women depends on von Willebrand factor and fibrinogen concentrations and blood group genotype. J. Thromb. Haemost., 5, 189–191 (2007).
  • Royal College of Obstetricians and Gynaecologists (RCOG): Green-top guideline No 37. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. RCOG, London, UK (2009).
  • Clark P , BatesS: North American and British guidelines for anti-thrombotic therapy: are we reaching consensus?Thromb. Res., 123(Suppl. 2), S111–S123 (2009).
  • Robertson L , WuO, LanghornePet al.: Thrombophilia in pregnancy: a systematic review.Br. J. Haematol., 132, 171–196 (2005).
  • Jick H , SloneD, WesterholmBet al.: Venous thromboembolic disease and ABO blood type. A cooperative study.Lancet, 1, 539–542 (1969).
  • Larsen TB , JohnsenSP, GislumM, MollerCA, LarsenH, SorensenHT: ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case–control study.J. Thromb. Haemost., 3, 300–304 (2005).
  • Clark P , TwaddleS, WalkerID, ScottL, GreerIA: Cost–effectiveness of screening for the factor V Leiden mutation in pregnant women.Lancet, 359, 1919–1920 (2002).
  • Carter Y , CapsM, MeissnerM: Deep venous thrombosis and ABO blood group are unrelated in trauma patients.J. Trauma Injury Infect. Crit. Care, 52, 112–116 (2002).
  • Wu O , RobertsonL, TwaddleSet al.: Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.Health Technol. Assess., 10(11), (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.